Lacerda, M. P. D., Dimopoulos, M., Pour, L., Kim, K., Voloshin, S., Sia, H., García, E. G., Min, C., Balarí, A. S., Špička, I., Robak, P., Hus, M., Zherebtsova, V., Hanna, M., Jadhav, V., Mouro, J., Khalaf, Z., Pirooz, N., Garrobo-Calleja, I., Eccersley, L., Manasanch, E., Hungria, V., Beksac, M. (2025). Impact of belantamab mafodotin–containing regimens on renal function in patients with Relapsed/Refractory multiple myeloma (RRMM) and mild/moderate renal impairment in the dreamm-7 and dreamm-8 trials. Blood. https://doi.org/10.1182/blood-2025-2260